Impact of frequent hemodialysis on anemia management: results from the Frequent Hemodialysis Network (FHN) Trials | Zendy

Daniel B. Ornt | Zendy; Brett Larive | Zendy; Anjay Rastogi | Zendy; Mohamad Rashid | Zendy; John T. Daugirdas | Zendy; Ann Hernandez | Zendy; Manjula Kurella Tamura | Zendy; Rita S. Suri | Zendy; Nathan W. Levin | Zendy; Alan S. Kliger | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Impact of frequent hemodialysis on anemia management: results from the Frequent Hemodialysis Network (FHN) Trials

Author(s) -

Daniel B. Ornt,

Brett Larive,

Anjay Rastogi,

Mohamad Rashid,

John T. Daugirdas,

Ann Hernandez,

Manjula Kurella Tamura,

Rita S. Suri,

Nathan W. Levin,

Alan S. Kliger

Publication year - 2013

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gfs593

Subject(s) - medicine , hemodialysis , anemia , intensive care medicine

The extent to which anemia management is facilitated by more frequent hemodialysis (HD) is controversial. We hypothesized as a preselected outcome that patients receiving HD six times (6×) compared with three times (3×) per week would require lower doses of erythropoietin-stimulating agents (ESA) and/or achieve higher blood hemoglobin (Hb) concentrations.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research